Department of Surgery, London, Ontario, Canada.
Division of Gastroenterology, Department of Medicine; London, Ontario, Canada.
Liver Transpl. 2023 Jun 1;29(6):618-625. doi: 10.1097/LVT.0000000000000100. Epub 2023 Mar 13.
Medical assistance in dying (MAiD) has been a legally approved practice in Canada since 2016. Only recently have patients undergoing MAiD also been considered as donors for liver transplantation (LT). This study aimed to evaluate a case series of LT outcomes for recipients with MAiD donors and was paired with a systematic literature review of studies assessing the efficacy of MAiD-associated liver donation. A retrospective chart review of patients registered within the LT Registry at London Health Sciences Centre (LHSC) in London, Ontario, Canada, that had received MAiD donor LT was conducted to develop a case series. Descriptive statistics were produced based on available patient outcomes information. The systematic review included euthanasia due to MAiD being a term exclusive to Canada. Case series had a 100% 1-year graft survival rate, with 50% of patients experiencing early allograft dysfunction but having no significant clinical outcome. A single case of postoperative biliary complication was reported. Median warm ischemic time ranged from 7.8-13 minutes among case series and literature reviews. Utilization of donation after circulatory death allografts procured after MAiD appears to be promising. Mechanisms associated with potential impact in postoperative outcomes include relatively lower warm ischemic time relative to donation after circulatory death Maastricht III graft recipients.
医疗辅助死亡(MAiD)自 2016 年以来在加拿大已成为一种合法的做法。最近,接受 MAiD 的患者也被认为是肝移植(LT)的供体。本研究旨在评估一组接受 MAiD 供体 LT 的患者的 LT 结果,并对评估与 MAiD 相关的肝捐赠功效的研究进行系统文献回顾。对在加拿大安大略省伦敦市 LHSC 的 LT 注册处注册并接受 MAiD 供体 LT 的患者进行了回顾性图表审查,以开发病例系列。根据可用的患者结局信息生成了描述性统计数据。系统评价包括安乐死,因为安乐死是加拿大独有的术语。病例系列的 1 年移植物存活率为 100%,50%的患者出现早期移植物功能障碍,但无明显临床结局。报告了 1 例术后胆并发症。病例系列和文献综述中,热缺血时间中位数范围为 7.8-13 分钟。似乎可以利用 MAiD 后获得的循环死亡供体进行捐赠。与术后结局相关的潜在影响的机制包括相对较低的热缺血时间,与接受 Maastricht III 供体的循环死亡供体相比。